Suppr超能文献

羟氯喹治疗声门下狭窄:争夺气道的新疗法。

Hydroxychloroquine for subglottic stenosis: a novel therapy in the battle for air.

机构信息

Department of Otolaryngology/Head and Neck Surgery, Hebrew University School of Medicine, Hadassah Medical Center, Jerusalem, Israel.

出版信息

Laryngoscope. 2010 Apr;120(4):743-4. doi: 10.1002/lary.20848.

Abstract

Upper airway obstruction due to subglottic edema and granulation tissue proliferation may cause severe morbidity and may be life threatening. Hydroxychloroquine interferes with antigen processing by means of raising lysosomal pH and immune response modulation. Herein, we present the outcome of a steroid-sparing treatment using hydroxychloroquine in an 80-year-old man with acquired subglottic stenosis and steroid dependency. Twice daily oral hydroxychloroquine at 2 mg/kg/day allowed cessation of systemic steroids without recurrence of the stenosis. Successful weaning of the hydroxychloroquine took place over a 5-month period.

摘要

由于声门下水肿和肉芽组织增生导致的上呼吸道阻塞可能导致严重的发病率,并可能危及生命。羟氯喹通过提高溶酶体 pH 值和免疫反应调节来干扰抗原处理。在此,我们报告了一名 80 岁男性获得性声门下狭窄和类固醇依赖患者使用羟氯喹进行类固醇节约治疗的结果。每日两次口服羟氯喹,剂量为 2mg/kg/天,可在不复发狭窄的情况下停止全身使用类固醇。羟氯喹成功减药历时 5 个月。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验